NasdaqCM - Delayed Quote USD

Sintx Technologies, Inc. (SINT)

5.15 -0.72 (-12.27%)
At close: June 7 at 4:00 PM EDT
5.10 -0.05 (-0.97%)
After hours: June 7 at 7:57 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,295.00
1,226.00
601.00
606.00
594.00
--
Cost of Revenue
889.00
784.00
265.00
449.00
475.00
--
Gross Profit
406.00
442.00
336.00
157.00
119.00
--
Operating Expense
13,404.00
13,800.00
11,671.00
10,777.00
9,869.00
--
Operating Income
-12,998.00
-13,358.00
-11,335.00
-10,620.00
-9,750.00
--
Net Non Operating Interest Income Expense
114.00
133.00
6.00
76.00
328.00
--
Other Income Expense
4,032.00
4,966.00
-710.00
1,235.00
2,393.00
--
Pretax Income
-8,852.00
-8,259.00
-12,039.00
-9,309.00
-7,029.00
--
Net Income Common Stockholders
-8,878.00
-8,285.00
-16,489.00
-9,309.00
-16,594.00
--
Average Dilution Earnings
-4,017.00
-5,320.00
-2,807.00
-696.00
-2,293.00
--
Diluted NI Available to Com Stockholders
-12,895.00
-13,605.00
-19,296.00
-10,005.00
-18,888.00
--
Basic EPS
-2.14
-2.22
-54.67
-37.70
-101.00
--
Diluted EPS
-2.14
-3.13
-60.81
-39.91
-108.00
--
Basic Average Shares
7,483.89
3,736.41
301.61
246.92
164.07
--
Diluted Average Shares
12,332.95
4,357.24
317.32
250.70
174.46
--
Total Operating Income as Reported
-12,998.00
-13,358.00
-11,335.00
-10,620.00
-8,504.00
--
Total Expenses
14,293.00
14,584.00
11,936.00
11,226.00
10,344.00
--
Net Income from Continuing & Discontinued Operation
-8,852.00
-8,259.00
-12,039.00
-9,309.00
-7,029.00
--
Normalized Income
-12,869.00
-13,208.00
-10,947.00
-10,149.00
-9,140.00
--
Interest Income
116.00
135.00
23.00
101.00
330.00
--
Interest Expense
2.00
2.00
17.00
25.00
2.00
--
Net Interest Income
114.00
133.00
6.00
76.00
328.00
--
EBIT
-8,850.00
-8,257.00
-12,022.00
-9,284.00
-7,027.00
--
EBITDA
-7,111.00
-6,600.00
-11,059.00
-8,634.00
-6,529.00
--
Reconciled Cost of Revenue
889.00
784.00
265.00
449.00
475.00
--
Reconciled Depreciation
1,739.00
1,657.00
963.00
650.00
498.00
--
Net Income from Continuing Operation Net Minority Interest
-8,852.00
-8,259.00
-12,039.00
-9,309.00
-7,029.00
--
Total Unusual Items Excluding Goodwill
4,017.00
4,949.00
-1,092.00
840.00
2,111.00
--
Total Unusual Items
4,017.00
4,949.00
-1,092.00
840.00
2,111.00
--
Normalized EBITDA
-11,128.00
-11,549.00
-9,967.00
-9,474.00
-8,640.00
--
12/31/2019 - 2/13/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

AEMD Aethlon Medical, Inc.
0.5859
+6.51%
 
VERO Venus Concept Inc.
0.9300
+50.24%
 
HSCS Heart Test Laboratories, Inc.
5.83
+1.04%
 
NUWE Nuwellis, Inc.
0.2110
-4.52%
 
RSLS ReShape Lifesciences Inc.
0.2250
-3.93%
 
BIOL BIOLASE, Inc.
0.1450
-3.27%
 
BJDX Bluejay Diagnostics, Inc.
0.4330
-6.88%
 
OPGN OpGen, Inc.
2.6399
-2.23%
 
ASXC Asensus Surgical, Inc.
0.3320
+41.40%
 
THMO ThermoGenesis Holdings, Inc.
0.5800
-0.70%